Citation
Botta-Orfila, Teresa, et al. "Identification of Blood Serum micro-RNAs Associated With Idiopathic and LRRK2 Parkinson's Disease." Journal of Neuroscience Research, vol. 92, no. 8, 2014, pp. 1071-7.
Botta-Orfila T, Morató X, Compta Y, et al. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. J Neurosci Res. 2014;92(8):1071-7.
Botta-Orfila, T., Morató, X., Compta, Y., Lozano, J. J., Falgàs, N., Valldeoriola, F., Pont-Sunyer, C., Vilas, D., Mengual, L., Fernández, M., Molinuevo, J. L., Antonell, A., Martí, M. J., Fernández-Santiago, R., & Ezquerra, M. (2014). Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease. Journal of Neuroscience Research, 92(8), 1071-7. https://doi.org/10.1002/jnr.23377
Botta-Orfila T, et al. Identification of Blood Serum micro-RNAs Associated With Idiopathic and LRRK2 Parkinson's Disease. J Neurosci Res. 2014;92(8):1071-7. PubMed PMID: 24648008.
TY - JOUR
T1 - Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
AU - Botta-Orfila,Teresa,
AU - Morató,Xavier,
AU - Compta,Yaroslau,
AU - Lozano,Juan José,
AU - Falgàs,Neus,
AU - Valldeoriola,Francesc,
AU - Pont-Sunyer,Claustre,
AU - Vilas,Dolores,
AU - Mengual,Lourdes,
AU - Fernández,Manel,
AU - Molinuevo,José Luis,
AU - Antonell,Anna,
AU - Martí,Maria José,
AU - Fernández-Santiago,Rubén,
AU - Ezquerra,Mario,
Y1 - 2014/03/20/
PY - 2013/08/06/received
PY - 2014/01/21/revised
PY - 2014/02/12/accepted
PY - 2014/3/21/entrez
PY - 2014/3/22/pubmed
PY - 2015/2/24/medline
KW - Parkinson's disease
KW - biomarker
KW - blood
KW - miRNAs
SP - 1071
EP - 7
JF - Journal of neuroscience research
JO - J Neurosci Res
VL - 92
IS - 8
N2 - Blood-cell-free circulating micro-RNAs (miRNAs) have been proposed as potential accessible biomarkers for neurodegenerative diseases such as Parkinson's disease (PD). Here we analyzed the serum levels of 377 miRNAs in a discovery set of 10 idiopathic Parkinson's disease (IPD) patients, 10 PD patients carriers of the LRRK2 G2019S mutation (LRRK2 PD), and 10 controls by using real-time quantitative PCR-based TaqMan MicroRNA arrays. We detected candidate differentially expressed miRNAs, which were further tested in a first validation set consisting of 20 IPD, 20 LRRK2 PD, and 20 control samples. We found four statistically significant miRNAs that were downregulated in either LRRK2 or IPD (miR-29a, miR-29c, miR-19a, and miR-19b). Subsequently, we validated these findings in a third set of samples consisting of 65 IPD and 65 controls and confirmed the association of downregulated levels of miR-29c, miR-29a, and miR-19b in IPD. Differentially expressed miRNAs are predicted to target genes belonging to pathways related to ECM-receptor interaction, focal adhesion, MAPK, Wnt, mTOR, adipocytokine, and neuron projection. Results from our exploratory study indicate that downregulated levels of specific circulating serum miRNAs are associated with PD and suggest their potential use as noninvasive biomarkers for PD. Future studies should further confirm the association of these miRNAs with PD.
SN - 1097-4547
UR - https://www.unboundmedicine.com/medline/citation/24648008/Identification_of_blood_serum_micro_RNAs_associated_with_idiopathic_and_LRRK2_Parkinson's_disease_
DB - PRIME
DP - Unbound Medicine
ER -